Adding Delayed Recall to the Alzheimer Disease Assessment Scale is Useful in Studies of Mild Cognitive Impairment But Not Alzheimer Disease

Por Sano, Mary, Raman, Rema, Emond, Jennifer, Thomas, Ronald G., Petersen, Ronald, Schneider, Lon S., Aisen, Paul S.
Publicado em 2011

Investigating Emergent Symptomatology as an Outcome Measure in a Behavioral Study of Alzheimer’s Disease

Por Tractenberg, Rochelle E., Gamst, Anthony, Thomas, Ronald G., Patterson, Marian, Schneider, Lon S., Thal, Leon J.
Publicado no J Neuropsychiatry Clin Neurosci (2002)

Dietary self-monitoring and its impact on weight loss in overweight children

Por Mockus, Danyte S., Macera, Caroline A., Wingard, Deborah L., Peddecord, Michael, Thomas, Ronald G., Wilfley, Denise E.
Publicado em 2011

Randomized controlled trials in mild cognitive impairment: Sources of variability

Por Petersen, Ronald C., Thomas, Ronald G., Aisen, Paul S., Mohs, Richard C., Carrillo, Maria C., Albert, Marilyn S.
Publicado no Neurology (2017)

Qualifying Change: A Method for Defining Clinically Meaningful Outcomes of Change Score Computation

Por Tractenberg, Rochelle E., Jin, Shelia, Patterson, Marian, Schneider, Lon S., Gamst, Anthony, Thomas, Ronald G., Thal, Leon J.
Publicado no J Am Geriatr Soc (2000)

Frequency of behavioral symptoms characterizes agitation in Alzheimer’s disease

Por Tractenberg, Rochelle E., Gamst, Anthony, Weiner, Myron F., Koss, Elisabeth, Thomas, Ronald G., Teri, Linda, Thal, Leon
Publicado no Int J Geriatr Psychiatry (2001)

Decline in verbal memory during preclinical Alzheimer's disease: Examination of the effect of APOE genotype

Por LANGE, KELLY L., BONDI, MARK W., SALMON, DAVID P., GALASKO, DOUGLAS, DELIS, DEAN C., THOMAS, RONALD G., THAL, LEON J.
Publicado em 2002

Efficacy of site-independent telemedicine in the STRokE DOC trial: a randomised, blinded, prospective study

Por Meyer, Brett C., Raman, Rema, Hemmen, Thomas, Obler, Richard, Zivin, Justin A., Rao, Ramesh, Thomas, Ronald G., Lyden, Patrick D.
Publicado em 2008

Plasma Urate and Progression of Mild Cognitive Impairment

Por Irizarry, Michael C., Raman, Rema, Schwarzschild, Michael A., Becerra, Lida M., Thomas, Ronald G., Peterson, Ronald C., Ascherio, Alberto, Aisen, Paul S.
Publicado em 2009

MRI Substudy Participation in Alzheimer Disease (AD) Clinical Trials: Baseline Comparability of a Substudy Sample to Entire Study Population

Por Raman, Rema, Thomas, Ronald G., Weiner, Michael W., Jack, Clifford R., Ernstrom, Karin, Aisen, Paul S., Tariot, Pierre N., Quinn, Joseph F.
Publicado em 2009

Clinical trial of an inhibitor of RAGE-Aβ interactions in Alzheimer disease

Por Galasko, Douglas, Bell, Joanne, Mancuso, Jessica Y., Kupiec, James W., Sabbagh, Marwan N., van Dyck, Christopher, Thomas, Ronald G., Aisen, Paul S.
Publicado em 2014

The Preclinical Alzheimer Cognitive Composite: Measuring Amyloid-Related Decline

Por Donohue, Michael C., Sperling, Reisa A., Salmon, David P., Rentz, Dorene M., Raman, Rema, Thomas, Ronald G., Weiner, Michael, Aisen, Paul S.
Publicado no JAMA Neurol (2014)

Age and APOE genotype influence rate of cognitive decline in non-demented elderly

Por Salmon, David P., Ferris, Steven H., Thomas, Ronald G., Sano, Mary, Cummings, Jeffery L., Sperling, Reisa A., Petersen, Ronald C., Aisen, Paul S.
Publicado em 2013

Reliability of Monitoring the Clinical Dementia Rating in Multicenter Clinical Trials

Por Schafer, Kimberly A., Tractenberg, Rochelle E., Sano, Mary, Mackell, Joan A., Thomas, Ronald G., Gamst, Anthony, Thal, Leon J., Morris, John C.
Publicado no Alzheimer Dis Assoc Disord (2004)

ADCS Prevention Instrument Project: Pharmacoeconomics: Assessing Health-related Resource Use Among Healthy Elderly

Por Sano, Mary, Zhu, Carolyn W., Whitehouse, Peter J., Edland, Steven, Jin, Shelia, Ernstrom, Karin, Thomas, Ronald G., Thal, Leon J., Ferris, Steven H.
Publicado em 2006

Demonstration of safety of intravenous immunoglobulin in geriatric patients in a long-term, placebo-controlled study of Alzheimer's disease

Por Gelmont, David, Thomas, Ronald G., Britt, Jonathan, Dyck-Jones, Jacqueline A., Doralt, Jennifer, Fritsch, Sandor, Brewer, James B., Rissman, Robert A., Aisen, Paul
Publicado no Alzheimers Dement (N Y) (2016)

A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease

Por Turner, R. Scott, Thomas, Ronald G., Craft, Suzanne, van Dyck, Christopher H., Mintzer, Jacobo, Reynolds, Brigid A., Brewer, James B., Rissman, Robert A., Raman, Rema, Aisen, Paul S.
Publicado no Neurology (2015)

High Dose B Vitamin Supplementation and Cognitive Decline in Alzheimer’s Disease: A Randomized Controlled Trial

Por Aisen, Paul S., Schneider, Lon S., Sano, Mary, Diaz-Arrastia, Ramon, van Dyck, Christopher H., Weiner, Myron F., Bottiglieri, Teodoro, Jin, Shelia, Stokes, Karen T., Thomas, Ronald G., Thal, Leon J.
Publicado em 2008

Peripheral and central effects of γ-secretase inhibition by semagacestat in Alzheimer’s disease

Por Doody, Rachelle S, Raman, Rema, Sperling, Reisa A, Seimers, Eric, Sethuraman, Gopalan, Mohs, Richard, Farlow, Martin, Iwatsubo, Takeshi, Vellas, Bruno, Sun, Xiaoying, Ernstrom, Karin, Thomas, Ronald G, Aisen, Paul S
Publicado no Alzheimers Res Ther (2015)

Antioxidants for Alzheimer Disease: A Randomized Clinical Trial With Cerebrospinal Fluid Biomarker Measures

Por Galasko, Douglas R., Peskind, Elaine, Clark, Christopher M., Quinn, Joseph F., Ringman, John M., Jicha, Gregory A., Cotman, Carl, Cottrell, Barbara, Montine, Thomas J., Thomas, Ronald G., Aisen, Paul
Publicado em 2012